Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

Bibliographic Details
Main Authors: Jawad, Mays, Yu, Ning, Seedhouse, Claire, Tandon, Karuna, Russell, Nigel H, Pallis, Monica
Format: Online
Language:English
Published: BioMed Central 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488582/
id pubmed-3488582
recordtype oai_dc
spelling pubmed-34885822012-11-05 Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia Jawad, Mays Yu, Ning Seedhouse, Claire Tandon, Karuna Russell, Nigel H Pallis, Monica Research Article BioMed Central 2012-09-26 /pmc/articles/PMC3488582/ /pubmed/23013471 http://dx.doi.org/10.1186/1471-2407-12-431 Text en Copyright ©2012 Jawad et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Jawad, Mays
Yu, Ning
Seedhouse, Claire
Tandon, Karuna
Russell, Nigel H
Pallis, Monica
spellingShingle Jawad, Mays
Yu, Ning
Seedhouse, Claire
Tandon, Karuna
Russell, Nigel H
Pallis, Monica
Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
author_facet Jawad, Mays
Yu, Ning
Seedhouse, Claire
Tandon, Karuna
Russell, Nigel H
Pallis, Monica
author_sort Jawad, Mays
title Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
title_short Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
title_full Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
title_fullStr Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
title_full_unstemmed Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia
title_sort targeting of cd34+cd38- cells using gemtuzumab ozogamicin (mylotarg) in combination with tipifarnib (zarnestra) in acute myeloid leukaemia
description
publisher BioMed Central
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488582/
_version_ 1611921247858327552

Similar Items